206B Pain Relief Spray

Heal Deeper. Move Faster. Live Bolder
Fast Acting, Natural Ingredients, Fresh Smell.

42 total reviews

Reduces Pain

Reduces Inflammation

Increases Mobility

Clinically Proven

Rs. 449.00

~~Rs. 799.00~~

43% off

Quantity

EFFECTIVE PAIN RELIEF. NO HEATING. NO COOLING. JUST HEALING.

Instant healing action : feel relief within minutes of application
Advanced absorption : penetrates deep for maximum effectiveness
24-hour comfort : long-lasting relief that keeps you moving
Ayurvedic power blend : Vijaya extracts, Boswellia & premium oils
Non-greasy formula : clean application with no sticky residue

Feel the difference. Heal with purpose.
Choose 206B.

View full details

Read The Science

The 206B Trial — The Pain Company

The 206B Clinical Trial · CTRI/2024/09/074336

Most pain sprays were never put through a trial.
Ours was.

Name: 206B Pain Relief Spray
Brand: The Pain Company
SKU: 206BSpray-1
Price: 449.00 INR
Availability: InStock

A double-blind, placebo-controlled study at KEM Hospital, Mumbai. 100 patients. Four weeks. Run by the head of orthopaedics — not by us. Here is everything it found, and everything it does not claim.

Where

KEM Hospital, Mumbai

Design

Double-blind · Placebo-controlled

Patients

100 enrolled · 95 completed

Adverse events

Zero

01 — The method

A test designed so we couldn't fool ourselves.

"Clinically tested" is a phrase anyone can print. This is what was actually behind it.

02 — What it found

Four weeks in, the two groups didn't look alike anymore.

Every number below is measured against the placebo group — the fairest comparison there is.

reported less pain

vs 27.7% on the look-alike oil

moved more freely

vs 40.4% — measured on the WOMAC joint index

adverse events

across all 100 patients, both groups

Both groups began at the same place — an average pain score of 8.3 out of 10. They did not finish there.

03 — The pain curve

Pain fell on both sides. It just fell further, and kept falling, on 206B.

Patients marked their pain on a 0–10 line at the start, at two weeks, and at four. This is the average of every patient, week by week.

Average pain score (0–10)

Lower is better · n=95

206BPlacebo

The honest read: at week 2 the gap was real but slim. The two lines pulled apart over time. This is recovery behaving like recovery — not a numbing hit that fades by lunch.

04 — Moving, not just hurting

Less pain is one thing. Climbing the stairs is another.

The WOMAC index scores the boring, real stuff: stiffness in the morning, getting out of a chair, walking, putting on socks. Here's the share of each group who measurably improved by week 4.

206Bimproved on joint pain & function

89.6%

Placebosame measure, same four weeks

40.4%

Stiffness, pain and physical function were scored separately. 206B beat the placebo on all three by week 4 (p < 0.0001) — statistician's shorthand for "this almost certainly isn't chance."

05 — The realest measure

Did people still reach for a painkiller anyway?

Both groups were handed backup tablets for bad days. A questionnaire can be hopeful. Whether you still swallow the diclofenac is not. Fewer people on 206B did.

206Bneeded a backup painkiller · week 4

22.9%

Placeboneeded a backup painkiller · week 4

42.6%

Roughly half as many people on 206B needed a rescue tablet — and they took no more medicine overall. Relief that doesn't quietly add to your pill count.

06 — Day-to-day life

One group's quality of life held. The other's slipped.

The SF-12 questionnaire asks how much your health gets in the way of ordinary life. Higher is better.

Quality-of-life score (SF-12)

Higher is better · n=95

206BPlacebo

Four weeks is short for a life to visibly change. So the signal here is modest and we'll treat it that way: 206B held the line where the placebo group drifted down.

07 — In the patients' own words

At the end, we asked them to rate their own month.

Forget the indices for a second. This is how patients described their own condition after four weeks.

206B77% said good or excellent · 0% said worse

15%

Good · 58%

Exc · 19%

Placebo25% said good or excellent · 11% said worse

11%

Poor · 45%

19%

15%

11%

Worse Poor Fair Good Excellent

08 — The fine print, up front

What this trial does not prove.

A study that only tells you the good parts isn't a study, it's an ad. So here are the edges of what we found.

The limits, plainly.

Read these before you read the headlines again.

It was an early, single-site pilot. One hospital, 100 people, four weeks. Strong enough to be worth shouting about — not large enough to be the last word. A bigger confirmatory trial is the honest next step.

It was tested on osteoarthritis of the knee, hip and spine, in adults aged 50–75. That's who the evidence is for. It does not, on its own, prove anything about gym soreness, a stiff neck from your laptop, or period cramps.

The early days were modest. At week 2 the pain difference wasn't yet statistically clear. The result built with time — which is the point, but it means 206B is not an instant fix.

The results are accepted for presentation at the SICOT World Orthopaedic Congress, 2026 — a serious international forum. That's a strong signal. It is not the same as being published in a peer-reviewed journal, and we won't pretend it is.

206B is an AYUSH-licensed herbal formulation, not a pharmaceutical. It's not a replacement for medical care. If your pain is severe, new, or not improving — see a doctor, not a label.

09 — The receipts

Don't take our word for it. Look it up.

The trial was registered before it began, which means the results couldn't be cherry-picked after the fact. Here's the paperwork.

Registered · Independent · Verifiable

CTRI/2024/09/074336

Clinical Trials Registry of India · prospectively registered 25 Sep 2024

Site

Seth GS Medical College & KEM Hospital, Parel, Mumbai — public hospital, est. 1926

Principal Investigator

Dr. Mohan Desai — Head of Orthopaedics, KEM Hospital

Design

Prospective · Randomized · Double-blind · Placebo-controlled

Conducted under

New Drugs & Clinical Trials Rules 2019 (CDSCO) · ICH-GCP · Declaration of Helsinki

Formulation

Boswellia serrata 50% · Vijaya extract 3% · MCT oil 47%

Accepted for presentation · SICOT World Orthopaedic Congress 2026

Verify on the Clinical Trials Registry of India →

We didn't run this trial to win an argument.
We ran it because the category never bothers to.

See the 206B spray →

Keep moving.

100 %

Plant-based formula

KEM

Clinically tested

AYUSH

Licensed

We’re Always Here for You – 24/7 Support

Need help? Our friendly support team is available around the clock to assist you with your queries, orders, and more.

It smells different from other pain sprays. What is that

That's Boswellia, the same plant burned as frankincense in temples for thousands of years. We didn't mask it with artificial fragrance. What you're smelling is the actual ingredient working. Warm, earthy, a little mysterious. Most people stop noticing it after a few uses. Some start to love it.

When will I actually feel a difference?

Not overnight, but faster than you'd expect. Some people notice less soreness and pain in a few days. The real change builds over 2 - 4 weeks because it's fixing the inflammation and pain from within, not just distracting your brain from it. Good things take a little time.

I don't feel any heat or tingling. Is it working?

Yes, that's literally the point. Moov creates that burning feeling because the burning IS how it works. 206B doesn't need to do that. It goes into your tissue quietly and gets to work. No sensation needed. No news is good news.

Can I use it every day?

You should. The more consistently you use it, the better it works. Daily use is safe, our clinical trial had patients using it three times a day for four weeks with zero issues.

Is it safe on skin? Will it irritate?

Very safe. No menthol, no capsaicin, nothing that burns or stings. MCT oil base, gentle, absorbs cleanly.

Will it stain clothes?

Give it 1–2 minutes to absorb before getting dressed and you're fine. White shirt + too much spray + zero waiting = faint mark. Just don't rush it.

Is it safe during pregnancy?

The ingredients used are recognised in Ayurvedic medicine, but neither has enough pregnancy-specific safety data for us to give you a confident yes. Please check with your doctor before using it.